February 2024 - PsychedelicNewsWire (PNW)

ThursdayFeb 29, 2024 11:00 am

Study Finds DMT Promising in Symptomatic Relief for Depression

DMT is a potent psychedelic that has shown potential in reducing depression symptoms. This naturally occurring substance can be found in different animals and plants. When inhaled or ingested, this substance produces intense auditory and visual hallucinations. Unlike other psychedelics such a psilocybin or LSD, which produce prolonged experiences, DMT’s effects are brief, which make it a more flexible and manageable therapeutic option. A new study examined the therapeutic potential of DMT and its effects on the psychological well-being of individuals. The study used data from a pair of complementary studies that involved 30 healthy volunteers who had previously used…

TuesdayFeb 27, 2024 11:00 am

Athletes Share How Psychedelics Helped Them Overcome Life-Changing Injuries

A recent CNN report has highlighted how several athletes used psychedelics to overcome life-changing injuries and the myriad of mental-health challenges these injuries caused. Canadian Daniel Carcillo began playing professional ice hockey after graduating high school and broke into the National Hockey League (NHL) by age 20. After a decade-long career that saw him play for the Los Angeles Kings, New York Rangers and Philadelphia Flyers, Carcillo was a two-time Stanley Cup winner on the cusp of a well-earned retirement. However, he says, seven diagnosed concussions left him with headaches, anxiety, depression and “dementia-like” symptoms, rendering him suicidal. The retired…

ThursdayFeb 22, 2024 11:00 am

Psychedelics Take Different Commercialization Approach from Marijuana

The growing psychedelic industry is charting its own path to commercialization instead of following cannabis’ footprints. The psychedelics industry is basing its approach on facts and research, unlike cannabis, which centered on legalization. Experts in the psychedelic field have been conducting research on the substances for decades now, which has led to the discovery of various benefits that psychedelics hold. Researchers started studying psychedelics in the 1950s, until two decades later when the Controlled Substances Act came into effect. This act made it illegal to hold, much less carry out research on these compounds, which were classified into different schedules.…

TuesdayFeb 20, 2024 9:45 am

Researchers Look into Possibility of Treating Borderline Personality Disorder Using Psychedelics

Researchers are considering the possibility of using psychedelic drugs such as MDMA to treat Borderline Personality Disorder (BPD). BPD is a debilitating mental disorder that hinders an individual’s ability to manage emotions and leads to high impulsivity; it also generally negatively affects relationships. People with BPD often have long-term feelings of emptiness and find it difficult to form a stable sense of identity. This can result in impulsive behaviors and self-destructive tendencies, including suicidal thoughts or self-harm. Intense fear of abandonment also leads to stormy and volatile relationships characterized by devaluation and idealization of partners. Current treatment protocols for borderline…

ThursdayFeb 15, 2024 10:45 am

New Study Says Psychedelics Could Boost Sexual Function

Psychedelics such as LSD and hallucinogenic mushrooms may improve sexual function after one undergoes a psychedelic experience. Researchers are reporting the results of a new study, which they believe is the first study to look into the effects of psychedelic substances on sex. For their research, the investigators gathered survey responses from an estimated 300 participants prior to and after a psychedelic experience that involved drugs such as magic mushrooms, DMT and ayahuasca. Respondents included individuals who were taking the drugs for ceremonial, wellness or recreational purposes, as well as a small group involved in a trial that evaluated the…

TuesdayFeb 13, 2024 10:45 am

Seizures of Magic Mushrooms by Authorities Rose as Demand Grew

In the last couple of years, we have seen interest in psychedelics increase as more studies uncover their hidden benefits. Interest in psilocybin, the psychoactive compound found in hallucinogenic mushrooms, has increased significantly following evidence of its benefits for a range of mental-health conditions, including post-traumatic stress disorder and depression. However, drug busts of magic mushrooms have also increased, with data from new research showing that the amount of psilocybin seized by authorities has more than tripled in the period between 2017 and 2022. The author of this new research, Joseph Palamar, stated that the study’s findings indicated that the…

ThursdayFeb 08, 2024 10:45 am

Study Finds Psychedelic Users More Prone to Unusual Visual Experiences

Research into psychedelics has increased significantly in the recent past, with growing evidence to support their therapeutic benefits for a range of disorders, among them alcoholism and depression. Now, a new study has found that people who use psychedelics such as psilocybin and LSD may experience increased unusual visual occurrences. The study looked into the possible side effects of psychedelics when used in a recreational setting. The focus outside of clinical settings comes from concern that using these drugs in uncontrolled environments may not be safe. For their research, the scientists looked into the intensity and prevalence of visual experiences…

TuesdayFeb 06, 2024 10:45 am

Exploring Gender Challenges within Nascent Psychedelics Industry

Most psychedelic research is still in its infancy and is concerned with understanding the mechanisms that allow psychedelics such as LSD and psilocybin mushrooms to deliver a myriad of mental health benefits. The existing body of scientific literature on the subject has found that several classic psychedelics have the potential to offer long-term relief against hard-to-treat mental disorders, including treatment-resistant depression and post-traumatic stress disorder. However, several questions about psychedelics remain. Of these questions, a commonly asked one is whether different genders respond to psychedelics differently. Do women respond differently to psychedelic-based treatments than men? Furthermore, how can physicians account…

MondayFeb 05, 2024 10:30 am

Canadian Companies Set to Reap Big from Psychedelics Exports to Australia

Several Canadian biotechnology companies are poised to make a killing in the Australian market after the county’s Therapeutic Goods Administration (TGA) allowed psychiatrists to prescribe MDMA and psilocybin in 2023. The TGA regulates therapeutic goods such as medical devices and prescription drugs in Australia. It approved the prescription of psilocybin, the main psychoactive agent in magic mushrooms, and MDMA by changing their classification in Australia’s Poisons Scheme. The TGA’s changes to the Poisons Scheme mean that the two psychedelics are considered Schedule 8 Controlled Drugs for specific uses. However, psilocybin and MDMA will remain in Schedule 9 (Prohibited Substances), which…

FridayFeb 02, 2024 1:21 pm

Hawaii Task Force Files Bill Creating Program for Medicinal Psilocybin Use

Hawaii recently introduced a new measure that would establish legal protections for psilocybin’s therapeutic use. Under SB 3019, eligible patients would be allowed to possess the psychedelic and receive it under the care of a trained facilitator. The legislation, which was sponsored by Senator Chris Lee, was introduced by a task force formed in 2023 to look into breakthrough therapies. While the measure won’t legalize the psychedelic, it would defend eligible patients and their caregivers from state laws against psilocybin. Under SB 3019, mental health professionals would be allowed to recommend therapeutic psilocybin for individuals who met the stipulated eligibility…

News and publishing service for psychedelic related companies

Contact us: 415.949.5050

Month: February 2024